To determine the mechanism(s) by which Chlamydia pneumoniae homes to and establishes persistent infection in atheromatous lesions, the effect of the interaction of monocytes/macrophages (U937 cells) with human umbilical vein endothelial cells (HUVECs) and transformed human arterial endothelial cells (HMEC-1s) on the susceptibility of endothelial cells to infection with C. pneumoniae was investigated. Infection was enhanced 4.7-fold (HUVECs) and 4.4-fold (HMEC-1s) after coculture at monocyte-to-endothelial cell ratios of 5 and 2.5, respectively. U937 cells also directly transmitted infection to the endothelial cells, and addition of U937 cell-conditioned media dose-dependently enhanced the infectivity 2.0-to 2.5-fold. The stimulation of infectivity was specific to endothelial cells, because coculturing of monocytes with epithelial cells did not enhance the susceptibility of epithelial cells to infection. The susceptibility of endothelial cells to infection with C. trachomatis and C. psittaci was not enhanced by the monocyte-derived factor(s).
The response-to-injury hypothesis of atherosclerosis suggests that atherosclerotic lesions can be triggered by multiple proinflammatory factors, including infectious agents [1] . Infection is now considered an independent risk factor for cardiovascular disease, in particular, because of the strong association that has been demonstrated between infection with the respiratory pathogen Chlamydia pneumoniae and atherosclerosis [2, 3] . This association is based on evidence from seroepidemiologic studies and the demonstration, by means of immunocytochemistry, polymerase chain reaction, and isolation, of the presence of the organism in atheromatous tissue.
Studies with a variety of animal models have recently demonstrated that chronic infection with C. pneumoniae can induce inflammation and contribute to the atherogenic process [4] [5] [6] [7] [8] .
In atherosclerotic mice and rabbits infected with C. pneumoniae, the organism disseminates from the lungs to establish persistent infection within atheromatous lesions in the aorta [9] [10] [11] . Data from mouse studies further suggest that mononuclear phagocytes (monocytes/macrophages) may play a variety of pathogenic roles in chlamydial infection of atherosclerotic lesions. For example, data from our studies with hypercholesteremic mice suggest that C. pneumoniae disseminates from lungs to atheromatous plaques via infected macrophages by hemato-genous and/or lymphatic routes. These infected macrophages may then establish foci of persistent infection and, in conjunction with other risk factors for atherosclerosis, accelerate the atherosclerotic process [12] . The mechanisms by which C. pneumoniae persists in macrophages and how infected macrophages transmit infection to other cells within the artery wall remains unknown.
In vitro studies that make use of vascular cells have, to date, shown that infection of human endothelial cells with C. pneumoniae up-regulates expression of adhesion molecules, including E-selectin or endothelial-leukocyte adhesion molecule (ELAM-1), intercellular adhesion molecule (ICAM-1), and vascular cell adhesion molecule (VCAM-1) [13] ; chlamydial heat-shock protein 60 stimulates the expression of adhesion molecules and the proinflammatory cytokine interleukin-6 by endothelial cells [14] ; infection of human macrophages induces foam cell formation when exposed to low-density lipoprotein [15] ; and C. pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor [16] .
In keeping with the previous in vivo and in vitro data, the following studies were designed to evaluate how the interaction of human monocyte-like cells with endothelial cells affects the subsequent infection of endothelial cells by C. pneumoniae. These studies should help explore how infected macrophages establish persistent infection within atherosclerotic lesions and thus contribute to the atherogenic process.
Materials and Methods
Chlamydial organisms. Chlamydial strains used were C. pneumoniae AR-39, a respiratory isolate [17] , and AO-3 [18] , an isolate from the coronary artery, C. trachomatis E/UW-5/Cx and L2/434/ Bu, and C. psittaci 6BC. Organisms were propagated in human [19] , and were purified by hypaque gradient centrifugation. Purified organisms were resuspended in chlamydial transport medium, sucrose-phosphate-glutamic acid, and were stored at Ϫ75ЊC in small aliquots until use.
Cell lines and cultures. A transformed human arterial endothelial cell line (HMEC-1) was obtained from E. W. Ades (Centers for Disease Control and Prevention, Atlanta) [20] . Human umbilical vein endothelial cells (HUVECs) were obtained from Clonetics (San Diego). Human monocyte-like cells (U937) derived from histiocytic lymphoma (ATCC CRL1593) [21] were obtained from W. Van Voorhis (Department of Medicine, University of Washington, Seattle). U937 cells are nonadherent to the surface of glass or plastic culture vessels. Endothelial cells were cultured in endothelial cell growth medium (Clonetics) supplemented with human recombinant epidermal growth factor (10 ng/mL), hydrocortisone (1.0 mg/mL), 2% fetal calf serum, gentamicin, amphotericin, and bovine brain extract. U937 cells were maintained in RPMI 1640 (Life Technologies Gibco BRL, Rockville, MD) supplemented with 10% heatinactivated fetal calf serum and 100 mg/mL each streptomycin and vancomycin. HL and HeLa 229 cells were maintained in Eagle MEM (Life Technologies Gibco BRL) supplemented with 10% heat-inactivated fetal calf serum and 100 mg/mL each of streptomycin and vancomycin.
Inoculation of cell culture. Endothelial and HL cells were trypsinized from stock cultures and plated at cells/well to 5 2 ϫ 10 achieve a cell monolayer in 24 h in 24-well culture plates. A 12-mm-diameter glass coverslip was placed in each well for ease of staining for microscopic observation and counting inclusions for assaying titers. For inoculations, the culture fluid was removed, and the cell monolayer washed 3 times with Hanks' balanced salt solution; 0.2 mL of inoculum was added per well, and the plate was centrifuged for 1 h at 700-800 g at 25ЊC. Because of the differences in susceptibility of cell lines, the optimal infectious doses, which produce 20-450 inclusions in 30 fields at magnification of ϫ400 for accuracy of the technique for infectivity assay according to Furness et al. [22] , were predetermined and used at an MOI of 1 for HL cells, 10 for HMECs, and 100 for HUVECs. After centrifugation, the inocula were removed, and 1 mL of culture medium was added. The plates were incubated in a CO 2 incubator at 35ЊC for 3 days.
U937 cells ( ) were placed in a 1 dram (4.0-mL) flat-bot- 6 1 ϫ 10 tomed culture vial to which 0.1 mL of organism suspension (MOI, 1) was added. The vial was centrifuged for 1 h at 700-800 g at 25ЊC. The inoculum was removed, and the cells were washed with 2 mL of Hanks' balanced salt solution. Inoculated cells were resuspended with 2 mL of RPMI 1640 medium supplemented with 2% fetal calf serum and were transferred to 24-well culture plates. Cultures were incubated in a CO 2 incubator at 35ЊC for different time periods as specified. Cells were pelleted by centrifugation at 500 g for 10 min, resuspended in 0.5 mL of sucrose-phosphateglutamic acid, and stored at Ϫ75ЊC until assayed for infectivity.
Coculture. U937 cells (1 mL suspended in RPMI 1640 culture medium supplemented with 2% fetal calf serum) were added to cell monolayers of preinfected HMECs or HL cells in 24-well culture plates at specified ratios. For coculturing U937 cells and HUVECs, a 50/50 (vol/vol) mixture of RPMI and endothelial cell growth medium was used, because HUVECs are more fastidious than HMECs and do not grow only in RPMI medium. The plates were incubated in a CO 2 incubator at 35ЊC. The U937 cells were first removed by washing before the endothelial and HL cells were assayed for infectivity. Two parameters of infectivity were measured: the first-passage titer, indicative of the inclusion counts in the primary endothelial cell culture, and the second-passage titration of the infectious units contained in the harvested endothelial cells.
Coculture with infected monocytes. Infected U937 cells were added to endothelial or HL cell monolayers, and the plates were centrifuged for 1 h at 700 g at 25ЊC. After centrifugation, the supernatant was removed, and 1 mL of RPMI 1640 culture medium supplemented with 2% fetal calf serum was added. Cultures were incubated in a CO 2 incubator at 35ЊC.
Culture with monocyte (U937 cell)-conditioned medium. Conditioned media were obtained from U937 cells ( /mL) grown 5 5 ϫ 10 in RPMI 1640 medium supplemented with 2% fetal calf serum for at least 1 day. The culture supernatants were harvested, cell debris was removed by centrifugation at 500 g for 10 min, and the supernatants were frozen at Ϫ20ЊC until use. Endothelial cells were fed with conditioned medium after inoculation with C. pneumoniae. Controls were fed with fresh RPMI 1640 medium supplemented with 2% fetal calf serum. After incubation for 3 days, coverslips were stained for inclusion counts, and the remaining wells were harvested and assayed for infectivity titers.
Quantification of infection. Infectivity titers were assayed in HL (C. pneumoniae) or HeLa 229 (C. trachomatis and C. psittaci) cells. A 24-h monolayer of HL or HeLa cells grown on a 12-mmdiameter coverslip in a 24-well culture plate was inoculated with 0.2 mL of the harvested cells. Inoculated plates were centrifuged for 1 h at 800 g at 25ЊC. After centrifugation, the inoculum was removed, and the culture vial was fed with 1 mL of MEM containing 0.6 mg/mL cycloheximide. After incubation for 2 days (C. trachomatis and C. psittaci) or 3 days (C. pneumoniae) at 35ЊC, coverslips were removed and fixed with methanol, air-dried, and stained with a Chlamydia genus-specific monoclonal antibody conjugated with fluorescein isothiocyanate. Inclusions were counted in 30 random fields at magnification of ϫ400. The infectivity titers (inclusion-forming units per milliliter) were adjusted for the dilution factor and inoculum size and were used for comparison. Duplicate or triplicate coverslips were counted in each experiment.
Statistical analysis. Statistical analysis was done by use of Student's t test.

Results
Preliminary observation that coculture of monocytes with endothelial cells enhances C. pneumoniae growth in endothelial cells.
To determine whether coculturing U937 and HMECs had an effect on the growth of C. pneumoniae in HMECs, HMECs were inoculated with C. pneumoniae AR-39 and were subsequently cultured with U937 cells at an initial ratio of 5 U937 cells to 1 HMEC. The C. pneumoniae titers in HMECs cocultured with U937 cells were 2.6-fold greater than cultures of infected HMECs alone (data not shown). In these initial experiments, titers in HL cells (1.3-fold greater for cocultured cells than for HL cells alone) were not affected by coculturing with U937 cells (data not shown). The enhancement of C. pneumoniae growth in HMECs by coculturing with U937 cells (2.6-fold) was greater than that observed by cycloheximide treatment of infected HMECs (1.7-fold). In comparison, the infectivity of C. pneumoniae in HL cells was enhanced 3.2-fold by cycloheximide (data not shown).
Susceptibility of different cell lines to infection with C. pneumoniae. The relative susceptibility of 4 cell lines (HL, U937, HMEC, and HUVEC) to infection by C. pneumoniae AR-39 was determined. As shown in previous studies [23] , the most susceptible cell line was HL and the least susceptible cell line was U937. The relative susceptibilities of other cell lines to C. pneumoniae compared with HL cells were 0.17 (day 3 cultures, ) for HMECs, 0.04 (day 3 cultures, ) for HUVECs, n = 3 n = 3 and 0.01 (day 4 cultures, ) and 0.001 (day 3 cultures, n = 4 ) for U937 cells (data not shown). n = 4
Optimal ratios of monocytes to endothelial cells for coculture. In the present studies, the optimal cell ratio of U937 and HMECs that would produce the greatest enhancement of C. pneumoniae growth in HMECs was determined. A range of ratios of U937 cells to HMECs was tested (range, 0. , and a ratio of 2.5 produced the greatest (average of 2 experiments, 4.4-fold) enhancement (table 1) . A ratio as small as 0.5 was also effective, yielding an average enhancement of 3.2-fold. Similar analysis was also done with HUVECs. A ratio of 5 produced the greatest enhancement (mean of 4.7-fold) for HUVECs (table 2) .
Cell-type specificity of infectivity enhancement by coculture. In keeping with the preliminary studies, the growth of C. pneumoniae AR-39 in HL cells was not enhanced by coculturing infected HL cells with U937 cells at any ratio tested (table 2) . In contrast, growth of AR-39 in HMECs and HUVECs was enhanced.
Infection of endothelial cells is enhanced by culturing with conditioned medium. After inoculation of HMECs with AR-39, infected cells were incubated with fresh medium or fresh medium supplemented with different concentrations (20%, 50%, and 100%) of conditioned medium from U937 cells cultured for 1, 2, or 3 days. As shown in table 3, there was dose-dependent growth enhancement in the presence of the U937 cell-conditioned medium. Thus, growth enhancement may also be mediated by a soluble factor produced by monocytes. The largest enhancement of growth was observed with conditioned medium from U937 cells cultured for 1 day.
Chlamydial strain specificity of growth enhancement. To determine whether growth enhancement by conditioned medium from cultured monocytes is specific to C. pneumoniae, additional chlamydial strains, including C. pneumoniae, C. trachomatis, and C. psittaci, were tested. As shown in table 4, the growth of only C. pneumoniae isolates was enhanced.
Transmission of C. pneumoniae infection to uninfected HMECs by coculturing with infected U937 cells. To study whether C. pneumoniae-infected U937 cells can transmit infection to other cell types, as well as promote growth of C. pneu- [23] . Enhancement of infectivity of C. pneumoniae in HMECs also was observed with coculture of HMECs with U937 cells infected at an MOI of 2 and 5 and cultured for 4 days. The magnitude of enhancement was 5.5-fold at an MOI of 2 and 3.8-fold at an MOI of 5 (data not shown).
Discussion
Infection of endothelial cells by C. pneumoniae is enhanced by coculturing with U937 cells. This enhancement may be mediated, in part, by a monocyte-derived soluble factor(s) in a dose-dependent manner but is clearly augmented by cell-to-cell contact. C. pneumoniae-infected monocytes can directly transmit infection to endothelial cells but also appear to independently enhance the infectivity of C. pneumoniae for endothelial cells. This activity is a specific pathogenic property of C. pneumoniae to endothelial cells, because coculture of monocytes with epithelial cells (HL) does not enhance the susceptibility of HL cells to infection with C. pneumoniae. In addition, the susceptibility of endothelial cells to infection with C. trachomatis and C. psittaci is not enhanced by U937 cell-conditioned media. Cumulatively, these experimental results indicate that this phenomenon is specific for C. pneumoniae infection of endothelial cells.
It has been reported that interaction of infected macrophages with endothelial cells induces up-regulation of human immunodeficiency virus [24] [25] [26] and cytomegalovirus [27] replication in macrophages and results in transmission of cytomegalovirus infection to vascular cells [27] . However, enhancement of microbial growth in nonphagocytic vascular cells by monocytes/ macrophages via cell-to-cell contact or soluble mediators has not been reported. All 3 major human arterial wall cell types involved in atherogenesis (endothelial cells, smooth muscle cells, and macrophages) are susceptible to infection with C. pneumoniae [23, 28] . In addition, C. pneumoniae has been detected in these 3 cell types in atheromatous lesions [29, 30] . Therefore, whether monocyte/macrophage-derived mediators enhance the susceptibility of smooth muscles cells, as well as macrophages in a paracrine manner, should be a worthwhile area for investigation.
In our studies, both human primary (HUVECs) and transformed (HMEC-1s [20] ) endothelial cells were shown to be affected by human monocytes derived from histiocytic lymphoma cells (U937 cells [21] ). Whether these observations extend to peripheral blood monocytes, as well as to differentiated tissue macrophages, and whether these findings occur in vivo requires further investigation. This is especially important since our previous observations indicate that C. pneumoniae disseminates from lungs to atheromatous plaques via infected mononuclear phagocytes by hematogenous or lymphatic routes to establish foci of persistent infection [12] . Data from the current study suggest that infected monocytes both directly transmit infection to endothelial cells and aid in the establishment of persistent infection by augmenting C. pneumoniae infection indirectly through secretion of factor(s) that further contribute in an as-yet-unknown mechanism.
The finding that direct cell-to-cell contact produces a greater enhancement than does conditioned media suggests several possibilities: (1) cell-to-cell contact is more effective in stimulating secretion by promoting binding and uptake of chlamydiae by endothelial cells, because dilution-and diffusion-related problems are avoided; (2) additional growth-promoting factors are produced by monocytes/macrophages or endothelial cells in response to cell-to-cell interaction; and (3) conditioned media may be devoid of essential nutrients or factors that normally help prevent infection. Clearly, the role of direct cell-to-cell contact is more pertinent to the in vivo situation, because mediators produced and secreted after monocyte-endothelial cell interactions are more likely to be retained at the site of interaction.
The mechanisms of enhancement by monocyte-endothelial cell interaction and the chemical and physical nature of the mediator(s) are yet to be elucidated. Understanding of the biologic function of cell-to-cell interaction and identification and purification of the active components of possible soluble mediator(s) should elucidate mechanisms by which monocytes enhance infectivity and facilitate development of preventive measures against C. pneumoniae.
